NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms
R.-M. Koerber, C. Krollmann, K. Cieslak, E. Tregel, T. H. Brümmendorf, S. Koschmieder, M. Griesshammer, I. Gütgemann, P. Brossart, R. Skoda, C. C. Kolbe, E. Latz, D. Wolf, L. L. Teichmann
This study shows that NLRP3 inflammasome activation drives JAK2V617F mutant myeloproliferative neoplasms by promoting inflammation, platelet production, and fibrosis, and that its inhibition can reverse disease features.
bioRxiv · Mar 9, 2024Cancer Biology